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GLYCOGEN IN SKELETAL MUSCLE serves multiple well-accepted roles in systemic glucose homeostasis. Postprandial hyperglycemia normally results in insulin-stimulated transport of glucose into skeletal muscle followed by direct glucose phosphorylation and incorporation into muscle glycogen. This process, termed glycogenesis, clears glucose from the systemic circulation and is impaired among patients with type 2 diabetes (3). Skeletal muscle glycogen also serves as an energy source for muscle during anaerobic glycolysis, and lactate produced from glycogen during a fast or prolonged exercise is a major substrate for hepatic gluconeogenesis. Less clear is the capacity of skeletal muscle for de novo synthesis of glycogen from 3-carbon precursors, or glyconeogenesis. Only one pathway is generally accepted for conversion of pyruvate to phosphoenolpyruvate (PEP) in mammalian tissues: carboxylation of pyruvate to oxaloacetate followed by decarboxylation to PEP via phosphoenolpyruvate carboxykinase (PEPCK). The alternative pathway, direct conversion of pyruvate to PEP via pyruvate kinase (ATP ϩ pyruvate 3 ADP ϩ PEP), is usually held to be insignificant (4, 16, 17) .
Although this conclusion is standard teaching in textbooks (21) , early studies (14) reported that the reaction is reversible based on the transfer of 32 P from PEP to ATP in rat muscle extracts. Later, Hiatt et al. (9) found essentially equal 14 C labeling in positions 1, 2, 5, and 6 in glucosyl units from glycogen synthesized by the liver exposed to [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C 1 ]pyruvate. This glucose-labeling pattern would be expected if pyruvate undergoes carboxylation to form a dicarboxylic acid in exchange with the symmetric intermediate, fumarate, before conversion to PEP. Diaphragm muscle, however, generated glycosyl units without any enrichment in glucose positions 1 or 6. These data demonstrated unequivocally that the [2- 14 C 1 ]pyruvate was not converted to the symmetrical tricarboxylic acid (TCA) cycle intermediate, fumarate, in the pathway to glucose production (9) . Donovan and Pagliassotti (6) , studying rabbit skeletal muscle, found that glycogen synthesis from lactate was identical when measured with [ If intermediates of the TCA cycle were involved in glyconeogenesis, site-specific loss of tracer and therefore different rates of glycogen synthesis would be expected. Krimsky (13) and Dyson et al. (7) found that reverse flux through skeletal muscle pyruvate kinase is sufficient to support significant rates of glyconeogenesis. More recently, Dobson et al. (5) argued that technical limitations in early studies of pyruvate kinase coupled with the high sensitivity of the reaction to free [Mg 2ϩ ] and pH interfered with initial studies of the thermodynamics of the reaction. They found that, under in vivo conditions, the mass action ratio was within a factor of three to six of the equilibrium value, and, based on this analysis, proposed that the reaction may be reversed under some conditions (5) . In summary, thermodynamic studies suggest that reverse flux through pyruvate kinase may occur in vivo. Experiments examining the conversion of 14 C-enriched lactate to glucose by striated muscle are consistent with two possible reaction pathways, reverse flux through the pyruvate kinase reaction or flux in the oxaloacetate/malate pool without exchange with fumarate. In this report, both pathways will be termed "direct transfer" because both pathways preserve the 14 C labeling pattern of pyruvate in glucose.
The carbon tracer labeling patterns in glucose cannot distinguish the two possible direct transfer pathways, but these alternatives could be resolved by examining the 13 C labeling pattern of oxaloacetate or malate. Reverse flux through the pyruvate kinase reaction bypasses the oxaloacetate/malate pool, whereas carboxylation of pyruvate to oxaloacetate/malate followed by decarboxylation to PEP without rearrangement due to exchange with fumarate will produce a unique labeling pattern in oxaloacetate. Because the concentration of oxaloacetate is low, the 13 C labeling pattern in glutamate can be used to measure oxaloacetate labeling in positions 1, 2, and 3. In this study, 2 H and 13 C nuclear megnetic resonance (NMR) analysis of glucose, glucosyl units from glycogen, or glutamate was performed on cultured myoblast cells, isolated muscle tissue, and whole animals treated with 2 H 2 O and/or 13 C-labeled tracers. The 13 C labeling pattern in glucose released in the medium from myotubes or minced, incubated muscle demonstrated small excess labeling due to direct transfer. However, the 13 C labeling pattern in glycogen from minced muscle was dramatically different from that seen in glucose in the medium and demonstrated glucose production exclusively by direct transfer. The 2 H NMR spectrum confirmed that very little skeletal muscle glycogen was released in the medium of incubated muscle. The 13 C NMR spectrum of glutamate from the same tissue did not show evidence that oxaloacetate was an intermediate in glucose production. Finally, the 13 C labeling in glycogen from skeletal muscle in vivo did not match the 13 C labeling in glucose from plasma and for the first time demonstrated glyconeogenesis in skeletal muscle in vivo through a direct transfer pathway.
METHODS

Materials. [U-
13 C3]lactate (98%), [U-13 C3]propionate (99%), 2 H2O (99.9%), and deuterated acetonitrile (99.8%) were obtained from Cambridge Isotopes (Andover, MA). Horse serum was obtained from Invitrogen (Carlsbad, CA). DSC-18 solid-phase extraction gel was obtained from Supelco (St. Louis, MO). Dulbecco's modified Eagle's medium (DMEM), FBS, Dulbecco's PBS (D-PBS), Dowex 50Wx8 -200 (a cation-exchange column), Amberlite IRA-67 (an anion-exchange column), and other common chemicals were purchased from Sigma-Aldrich (St. Louis, MO).
Muscle cell culture. C 2C12 (a mouse myogenic cell line) myoblasts were proliferated in growth media consisting of DMEM and 20% FBS in 5% CO 2 at 37°C. When myoblasts were grown to confluence, the media was changed to differentiation media consisting of DMEM and 2% horse serum. The differentiation media was changed every 2 days. After 5-7 days in differentiation media, myotubes with multiple nuclei were formed. These myotubes were washed with D-PBS and then further incubated for 5 h with either D-PBS containing 20 Whole animal studies. The study was approved by the Institutional Animal Care and Use Committee at the University of Texas Southwestern Medical Center. Twenty-four-hour-fasted rats (ϳ430 -500 g) received an intraperitoneal injection of sodium lactate (2 g/kg body wt) enriched with 10% [U-
13 C3]lactate under isoflurane anesthesia. The rats were placed back into their cage where they quickly awakened and were allowed free access to water. After 3 h of injection, blood was drawn from the inferior vena cava under pentobarbital sodium anesthesia, and the liver and muscle tissue from the hindlimbs were freeze-clamped and kept under Ϫ80°C for subsequent processing.
Sample processing for NMR analysis. A 5-to 10-g portion of skeletal muscle tissue and liver tissue was used for glycogen extraction and purification (18) . Isolated glycogen was dissolved in ϳ5 ml of sodium acetate solution (10 mM, pH 4.8) and incubated with amyloglucosidase (50 mg glycogen/20 units) for 4 h at 50°C for hydrolysis into glucose. Blood from animals and media from myotube or tissue incubation were deproteinized by adding cold perchloric acid to a final concentration of 7% by volume. After neutralization with KOH and centrifugation, the supernatant was lyophilized. Glucose in the dried residue was purified by passing through two columns, a cation-exchange column and an anion-exchange column. Glucose was eluted through the columns with deionized water, lyophilized, and subsequently converted to monoacetone glucose (MAG, Fig. 1 ). This was accomplished by suspending the dried glucose in 3.0 ml of acetone containing 120 l of concentrated sulfuric acid. The mixture was stirred for 4 h at room temperature to yield diacetone glucose. After addition of 3 ml of water, the pH was increased to 2.0 by addition of Na 2CO3 (1.5 M). The mixture was stirred for 24 h at room temperature to convert diacetone glucose into MAG. The pH was then further increased to ϳ8.0 by adding Na 2CO3. Acetone was evaporated under a vacuum, and the sample was freeze-dried. MAG was extracted into 3 ml of hot ethyl acetate (5ϫ) that was subsequently removed by vacuum evaporation. The resulting MAG was further purified by passage through a 3-ml DSC-18 cartridge using 5% acetonitrile as eluent. The effluent was freeze-dried and stored dry before NMR analysis. For isolation of glutamate, muscle tissue (ϳ5-10 g) was treated with cold perchloric acid (8%), neutralized with KOH, and freeze-dried. Glutamate was isolated by ion-exchange chromatography as described previously (11) .
For 2 H NMR measurements, MAG was dissolved in a mixture of 90% acetonitrile-10% water (160 l). After each 2 H NMR acquisition, the MAG samples were lyophilized and resuspended in 90% deuterated acetonitrile-10% water for 13 C NMR measurements. Glutamate was dissolved in 2 H2O (160 l) for 13 C NMR measurement. NMR spectroscopy. All NMR spectra were collected using a Varian ANOVA 14.1 T spectrometer (Varian Instruments, Palo Alto, CA) equipped with a 3-mm broadband probe with the observe coil tuned to 2 H (92.1 MHz) or 13 C (150 MHz). Proton-decoupled 2 H NMR spectra were acquired using a 90°pulse (12.5 s), 920-Hz sweep width, 1,836 data points, and a 1-s acquisition time with no further delay at 50°C. Typically 20,000 -80,000 scans were averaged for MAG requiring ϳ5-24 h. Proton decoupling was performed using a standard WALTZ-16 pulse sequence. 13 C NMR spectra of MAG were collected using 52°pulse (6.06 s), 20,330 Hz sweep width, 60,992 data points, and a 1.5-s acquisition time with no further delay at 25°C (10). Typically, 10,000 -40,000 scans were averaged requiring ϳ5-18 h.
Proton-decoupled 13 C NMR spectra of glutamate were obtained using a 45°pulse (5.0 s), 34,965-Hz sweep width, 104,986 data points, and a 1.5-s interpulse delay at 25°C. Spectra were averaged 7,000 -30,000 scans requiring ϳ6 -25 h.
The notations used in 13 C NMR analysis such as C5D56 represents the following: "C5" for the carbon position of glucose and "D56" for doublet arising from spin-spin coupling of carbons 5 and 6. The Q in C5Q means quartet or doublet of doublets arising from coupling of carbon-5 with both carbons-4 and -6. C5S means the singlet resonance of carbon-5. Notations for other carbon resonances are used in a similar way in this study. All NMR spectra were analyzed using the curve-fitting routine supplied with NUTS PC-based NMR spectral analysis program (Acorn NMR, Freemont, CA).
Measurement of excess isotope enrichment. A 2 H NMR spectrum of MAG derived from glucose without isotope enrichment ( Fig. 2A) shows 2 H resonances in the seven aliphatic hydrogens in the glucose skeleton and in the two methyl groups in the monoacetone adduct. The peak area of each 2 H resonance was defined as AH1 Ϫ AH6S depending on hydrogen position in glucose. The total peak areas of two 2 H natural abundance methyl resonances were defined as Amethyl. The ratio of each MAG resonance in the 2 H NMR spectrum compared with Amethyl is theoretically 1:6 since there are 6 hydrogens that contribute to the two methyl groups. The measured ratios for natural abundance glucose were slightly higher (ϳ0.20), likely because of a longer spin-lattice relaxation time of deuterons in the methyl position (Table 1) . With the use of this correction factor, the 2 H enrichment above natural abundance (termed excess enrichment) could be determined by comparing the areas of each 2 H resonance in MAG derived from a tissue sample with the natural abundance signals arising from the two methyl resonances, M1 and M2 (Fig. 1) .
Similar considerations apply to analysis of the 13 C spectra. Because each 13 C is present at natural abundance levels of 1.1%, the probability of having two 13 Cs as nearest neighbors in the same molecule is 0.000121 or 0.0121%. A 13 C NMR spectrum of MAG containing only natural abundance levels of 13 C is shown in Fig. 3A (only the carbon-2 and carbon-5 resonances are shown for clarity). The small doublets surrounding the more intense singlets in each resonance arise from 13 C-13 C spin-spin coupling between natural abundant levels of 13 C in each neighboring carbon (D12 and D23 in the carbon-2 resonance and D45 and D56 in the carbon-5 resonance). The natural abundance 13 C signal from the methyl groups of MAG was also observed. The area of the 13 C singlet of each carbon was defined as AC1S Ϫ AC6S, the areas of doublets as AC1D12 Ϫ AC6D56, and the summed peak areas of two 13 C natural abundance methyl resonances were defined as Amethyl. The ratio of each doublet area compared with Amethyl in the 13 C NMR spectrum of natural abundance MAG should be 0.000121/(2 ϫ 0.011) ϭ 0.0055, exactly as observed within experimental error (Table 2 ). Any enrichment above this level was considered excess. The enrichment of quartet (Q, or doublet of doublets) in 13 C NMR spectra cannot be estimated using natural abundance MAG directly because natural abundance Q is essentially 0% and cannot be detected. (Fig. 4) . In whole animals, skeletal muscle glycogen synthesis occurs through both glycogenesis (phosphorylation of blood glucose) and perhaps glyconeogenesis (de novo glycogen synthesis). Thus the labeling pattern in skeletal muscle glycogen is the weighted sum of glucose derived from liver and directly transferred to glycogen plus possible in situ glyconeogenesis. where EC2D12, muscle glycogen is the excess enrichment (%) of C2D12 in skeletal muscle glycogen, EC2Q, muscle glycogen is the excess enrichment (%) of C2Q in skeletal muscle glycogen, AC2Q, blood glucose is the peak area of C2Q of blood glucose, and AC2D12, blood glucose is the peak area of C2D12 of blood glucose. The same principle can be applied to estimate the origins of [4,5,6- 13 C3]glucose unit of muscle glycogen. Statistical analysis. The data are expressed as means Ϯ SD. Comparisons between groups were performed using one-way ANOVA. Differences in mean values were considered statistically significant at a probability level of Ͻ5% (P Ͻ 0.05).
RESULTS
Glucose released by myotubes. Myotubes were exposed to 5% 2 H 2 O and unlabeled glucose (protocol 1). 2 H enrichment in medium glucose at the hydrogen-2 position tended to be higher than natural abundance 2 H, but the difference did not reach statistical significance (P ϭ 0.08, Table 1 ). There was no excess enrichment in hydrogen-6 (Table 1) . In a second series of experiments, myotubes were exposed to conditions designed to stimulate glucose production: 20 mM [U- 13 Values are means Ϯ SE. NMR, nuclear magnetic resonance; MAG, monoacetone glucose. MAG was derived from natural abundance (NA) glucose (n ϭ 6), from medium glucose of myotubes (protocols 1-3, n ϭ 6 for each), and from medium glucose (n ϭ 10) and skeletal muscle glycogen (n ϭ 4) in tissue incubation. Each value is the ratio of peak area of each resonance normalized by areas of methyl resonances of MAG on 2 hydrogen-1 and hydrogen-2 positions of medium glucose, about two times natural abundance (Table 1) , but again there was no excess enrichment in position 6. When the glutamine concentration was increased from 2 to 10 mM (protocol 3), the excess enrichments at hydrogen-1 and hydrogen-2 positions were even higher (Table 1 and Fig. 2B ), but 2 H labeling in position 6 was not significantly different from natural abundance. The presence of excess 2 H label in position 2 is generally accepted as evidence of proton exchange at the level of glucose 6-phosphate isomerase, and excess 2 H label in position 1 is due to equilibration with mannose-6-phosphate (2). Together, the low level of 2 H enrichment in each carbon compared with the concentration of 2 H in the medium suggests a low rate of gluconeogenesis.
In the 13 C NMR analysis, the dominant resonances from glucose in the medium were singlets resulting from natural abundance 13 C and the doublets due to adjacent natural abundance 13 C nuclei (doublets due to J 1,2 , J 2,3 , J 4,5 , and J 5, 6 ). However, in some instances, glucose from the medium also showed a quartet due to [4,5,6-13 C 3 ]glucose at levels greater than natural abundance in protocols 2 and 3 ( Fig. 3B and Table  2 ). The appearance of C5Q demonstrates that it originated from [U- 13 C 3 ]lactate because natural abundance [4,5,6-13 C 3 ]glucose cannot be detected by 13 C NMR analysis in this study (inner two components of the C5Q quartet overlap with the singlet in Fig. 3B ). Although resonances due to J 4,5 and J 5,6 were detected, these signals were not significantly greater than natural abundance. Interestingly, there was no evidence of the existence of excess [1,2,3-13 C 3 ]glucose, which would expected under the equilibrium of the triose phosphate isomerase reaction. The 13 C spectra demonstrated a small amount of glucose synthesis in myotubes by direct transfer.
Analysis of incubated, minced skeletal muscle.
2 H enrichment in glucose from the medium of incubated skeletal muscle was essentially indistinguishable from the glucose produced by myotubes (Table 1) . In contrast to glucose isolated from the medium, muscle glycogen from incubated, minced muscle showed very intense 2 H enrichment in glucose units (Table 1  and Fig. 2, C and D) . The excess enrichment in the hydrogen-2 position of glycogen was 40-fold higher than medium glucose. Because the resonances labeled M1 and M2 are the natural abundance 2 H signals from MAG, these signals provide an internal standard for comparison of Fig. 2, C and D. The difference between the labeling of glucose isolated from the medium and glycogen demonstrates that the overwhelming majority of glucose 6-phosphate produced in muscle was directed toward muscle glycogen rather than released in the medium. Experiments performed with [U- 13 C 3 ] propionate in the incubation medium in addition to unlabeled lactate (protocol 5) did not affect the 2 H enrichment pattern in muscle glycogen and medium glucose (spectra not shown).
A very small amount of excess [1,2,3-13 C 3 ]glucose and [4,5,6-13 C 3 ]glucose was observed in the medium (Table 2 and Fig. 3C ) and was qualitatively similar to results from myotubes. However, glycogen derived from [1,2,3-13 C 3 ]glucose and [4,5,6-13 C 3 ]glucose isotopomers amounted to 1.13 and 1.39%, respectively, perhaps 1,000-fold greater than that found in medium glucose. This dramatic difference is easily appreciated by comparing Fig. 3, C and D Table 2 ). Insets: D12, doublet from coupling of carbon-1 with carbon-2; D23, doublet from coupling of carbon-2 with carbon-3; Q, doublet of doublets, or quartet, arising from coupling of carbon-2 with both carbons-1 and -3, or from coupling of carbon-5 with both carbons-4 and -6; D45, doublet from coupling of carbon-4 with carbon-5; D56, doublet from coupling of carbon-5 with carbon-6; S, singlet. almost exclusively as glycogen rather than being released into the medium.
If glycogen was being synthesized via the direct transfer pathway [ Values are means Ϯ SE. 13 C NMR analysis of MAG derived from NA glucose (n ϭ 6), from medium glucose of myotubes (protocols 2-3, n ϭ 6 for each), and from medium glucose (n ϭ 10) and skeletal muscle glycogen (n ϭ 6) in tissue incubation. Each value is the ratio of peak area of each resonance normalized by areas of methyl resonances of MAG on 13 C NMR spectra (Aeach resonance/Amethyl). Nos. in parentheses are excess 13 C enrichment (%). The protocols are described in the text and are summarized in the legend to Table 1 .ND, not detectable. *Significantly different from NA glucose, P Ͻ 0.05. (Fig. 6, A and B 13 C enrichment pattern in glutamate. The possibility that oxaloacetate is an intermediary pool in glucose production also was tested by addition of [U- 13 C 3 ]propionate to the incubation medium of minced skeletal muscle. There was no 13 C excess enrichment in muscle glycogen, but labeling was observed in muscle glutamate (spectra not shown). Because there is only one pathway for propionate to enter the TCA cycle, via succinyl-CoA (Fig. 4) , the absence of 13 C enrichment in glycogen demonstrates that flux through PEPCK is negligible under these conditions. 13 [5, [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]glucose are abundant in liver glycogen and blood glucose. The area of the quartet relative to the doublet due to J 1,2 (A C2Q /A C2D12 ) in carbon-2 resonance was 0.59, 0.53, and 4.23 in liver glycogen, blood glucose, and skeletal muscle glycogen, respectively. The area of the quartet in carbon-5 relative to the doublet due to J 5, 6 (A C5Q /A C5D56 ) was 0.85, 0.73, and 4.90, respectively (Fig. 7A) . Based on the disproportionate amplitude of the quartet signal in muscle glycogen, it was estimated that 88% of [1,2,3-13 C 3 ]glucose in muscle glycogen originated from glyconeogenesis and the remainder from blood glucose. Similarly, 87% of [4,5,6-13 C 3 ]glucose units originated from glyconeogeneisis based on carbon-5 analysis. According to the calculation based on these percentages and the enrichments of glucose isotopomers (Table 3) , ϳ70% of multiplelabeled glucose units in skeletal muscle glycogen was synthesized through a direct transfer pathway from [U- 13 C 3 ]lactate in whole animals while the remaining 30% was from blood glucose phosphorylation (Fig. 7B) .
DISCUSSION
This study demonstrated direct transfer of lactate to glucose in skeletal muscle both in vitro and in vivo. It is the first demonstration of this pathway in vivo. Surprisingly, under these conditions, ϳ70% of multiple-labeled glucosyl units of skeletal muscle glycogen in whole animals originated through reverse flux of pyruvate kinase while ϳ30% originated from phosphorylation of blood glucose. Nevertheless, the physiological relevance of these observations is not known. In particular, it is already well-established that direct transfer of blood glucose into muscle glycogen plays an essential role in systemic glucose homeostasis, and it seems very unlikely that reverse flux could play any meaningful role under postprandial conditions where the concentration of lactate is low. It is conceivable that reverse flux could be relevant in glycogen replenishment after intense exercise when the concentration of lactate is increased up to 10 -12 mM (8, 22) , which is closer to Fig. 7 . A: graph of peak area ratios, AC2Q/ AC2D12 and AC5Q/AC5D56, based on 13 C NMR analysis of MAG derived from liver glycogen, blood glucose, and skeletal muscle glycogen of whole animals treated with [U-
13 C3]lactate (spectra shown in Fig. 6) . B: graphs showing the relative distributions of multiply labeled glucose units in skeletal muscle glycogen originated from blood glucose (ϳ30%) and from de novo glycogen synthesis (ϳ70%) of the whole animals (spectra shown in Fig. 6C ). **P Ͻ 0.01 and ***P Ͻ 0.001. Values are means Ϯ SE. 13 C NMR analysis of MAG derived from liver glycogen (n ϭ 6), blood glucose (n ϭ 6), and skeletal muscle glycogen (n ϭ 6) of whole animals treated with ͓U-13 C3͔lactate. Each value is the ratio of peak area of each resonance normalized by areas of methyl resonances of MAG on 13 C NMR spectra (Aeach resonance/Amethyl). Nos. in parentheses are excess 13 C enrichment (%). Significantly different from blood glucose (*P Ͻ 0.01 and †P Ͻ 0.001).
the concentration of lactate used in the minced muscle studies, 20 mM (Fig. 3D ). This hypothesis remains to be examined. The strongest evidence of the direct transfer comes from exposure of minced muscle tissues to 20% [U- 13 Fig. 3D absolutely excludes exchange of the gluconeogeneic precursor with fumarate in the TCA cycle. These data from the incubated skeletal muscle are fully consistent with the radiotracer studies by Hiatt et al. (9) in isolated rat diaphragm and by Donovan and Pagliassotti (6) in perfused rabbit skeletal muscle.
The current study extends earlier work by showing that the 13 C enrichment patterns in skeletal muscle glycogen in vivo is also due predominantly to direct transfer from lactate to glucose. The in vivo experiment is somewhat more difficult to interpret than incubated skeletal muscle because hepatic gluconeogenesis from lactate will produce plasma glucose with complex labeling patterns due to recycling of 13 C in the liver. However, analysis of 13 C isotopomers in plasma glucose allowed for correction of the effects of hepatic gluconeogenesis followed by glycogen synthesis in skeletal muscle. The amount of [1,2,3-13 C 3 ]glucose (or [4,5,6-13 C 3 ]glucose) in skeletal muscle glycogen was far greater than could be contributed by plasma glucose and therefore must be due to in situ skeletal muscle glyconeogenesis.
Although these experiments confirmed a direct transfer pathway for glucose production by skeletal muscle, the 13 C labeling pattern in glucose could in principle be consistent with flux into oxaloacetate followed by conversion to PEP without exchange with fumarate. This seems unlikely for a number of reasons. First, TCA cycle enzymes in skeletal muscle mitochondria are active, and "reverse flux" into fumarate from malate and oxaloacetate is well-studied and complete or nearly so in the liver (12, 15, 20) . Second, the possibility that oxaloacetate was involved in glyconeogenesis was also tested by adding [U- 13 C 3 ] propionate. Entry of [U- 13 C 3 ] propionate in the TCA cycle via propionyl-CoA, methylmalonyl-CoA, and succinylCoA must produce a mixture of 13 C isotopomers in PEP. If glycogen is derived from oxaloacetate through PEPCK, one would expect many more isotopomers to appear in glycogen. Because 13 C enrichment was not observed in glycogen under these conditions, this eliminates the possibility of flux coming through PEPCK. Third, 13 C NMR analysis of muscle glutamate during exposure to [U- 13 C 3 ]lactate confirmed flux through pyruvate dehydrogenase, but negligible flux through pyruvate carboxylase. Finally, the absence of [1,2-13 C 2 ]glucose (or [5, [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]glucose) in the incubated skeletal muscle exposed to [U- 13 C 3 ]lactate demonstrates the absence of reverse exchange with fumarate. The other doublet in position 2 or 5, due to [2,3- 13 C 2 ]-or [4, [5] [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]glucose, could arise from "forward" flux through the cycle. The absence of these isotopomers could be attributed to dilution of TCA cycle intermediates by very high flux through anaplerotic pathways, which is typically at least 10 times TCA cycle flux. However, very high anaplerotic flux with unlabeled substrates is not consistent with the observed 13 C spectrum of glutamate.
These results also bear on the functional significance of the newly discovered glucose-6-phosphatase ␤ in muscle (19) . The presence of this phosphatase would seem to allow glucose release in the circulation from skeletal muscle glycogen. However, in this study, the 2 H and 13 C labeling patterns in medium glucose were quite different from glycogen, and the whole animal data showed no evidence of glucose release from muscle. Based on both the 2 H and 13 C NMR data, glucose 6-phosphate formed from lactate is directed almost exclusively into glycogen. Although 2 H labeling of glucose from 2 H 2 O is a rich source of information, little work has been done using 2 H NMR analysis of skeletal muscle metabolism.
In summary, the 13 C distribution in glucose produced by glyconeogenesis in skeletal muscle from [U- 13 C 3 ]lactate was not consistent with flux through a "well-mixed" TCA cycle. If lactate is converted to glucose in muscle via a TCA cycle intermediate, then other rather implausible conditions must be invoked. The alternative interpretation is significant reverse flux through the pyruvate kinase reaction. Despite early thermodynamic studies indicating that the reaction is essentially irreversible under cellular conditions (4, 16, 17) , both tracer and subsequent thermodynamic studies in isolated systems (5-7, 9, 14) reported significant reverse flux. The current study demonstrated this pathway in vivo. Because skeletal muscle glycogen plays numerous important roles in carbohydrate homeostasis, it will be important to properly quantify all pathways feeding glycogen production and the physiological relevance of each.
